NFKB1 and myalgic encephalomeyelitis/chronic fatigue syndrome: Additionally, APS reversed the abnormal expression of Nrf2, NF-κB, and their downstream factors in the brain–gut axis and alleviated the reduction in SCFAs in the cecal content associated with CFS.